White heather

White Heather (Calluna vulgaris (L.) Hull): A Comprehensive Reference

1. Identity, Taxonomy, and Natural Source

"White heather" is a colour variant of the species commonly known as common heather, ling, or Scotch heather, whose accepted scientific name is Calluna vulgaris (L.) Hull. Calluna vulgaris L. Hull is the sole species in the genus Calluna in the Ericaceae family. The genus name derives from the Greek kallyno, meaning "to clean" or "to sweep," reflecting the plant's historical use as a broom material. The species epithet vulgaris simply means "common." In supplement and herbal commerce, both white- and pink/purple-flowered forms are used interchangeably, and all share the same pharmacological profile; white-flowered plants are not pharmacologically distinguished from the more common pink-purple form in the scientific literature.

Calluna vulgaris, belonging to the Ericaceae family, is an invasive plant that has widely spread from Europe all across Asia, North America, Australia and New Zealand. Being able to survive in rigid soil and environmental conditions, it is nowadays considered to be of high nature-conservation value, and is known for its nutritional and medicinal properties, standing out for its varied physiochemical composition, spotlighting a wide range of biological activity. C. vulgaris can be found in most parts of Europe and Northern America from lowland up to alpine regions.

The plant is an evergreen woody shrub. Common heather is often larger than related species (up to 1 m); it has small flowers—pink, purple, or white—with 4 petals, the flowers arranged in terminal clusters. The very small leaves are opposite, applied in 4 rows along the reddish and tortuous stems. The medicinal parts are the flowering stalks, aerial parts (herb), leaves, and flowers; the flowering stems are harvested in the autumn and dried for later use.

1.1 Common Names and Synonyms

• Accepted scientific name: Calluna vulgaris (L.) Hull
• Common names: Common Heather, White Heather (white-flowered form), Ling, Scotch Heather, Heather
• Family: Ericaceae
• Former classification: Previously placed in the genus Erica, reclassified by Richard Salisbury into Calluna

1.2 Common Preparations and Forms

The plant is used in several commercial and traditional forms:

• Herbal infusion (tea): Dried flowering shoots steeped in hot water
• Hydroethanolic extract (tincture/standardized dry extract): Prepared with water-ethanol mixtures, with 70% ethanol being studied specifically in research
• Aqueous extract: Prepared with water alone; used extensively in antimicrobial in-vitro studies
• Ethyl acetate and ethanol extracts: Used in laboratory and pharmacological investigations for isolation of specific compounds
• Supercritical CO₂ extract: A research-stage preparation used to isolate triterpenic acids
• Topical liniment/poultice: Traditional preparation, macerated plant material applied externally
• Homeopathic dilutions: Available in various CH potencies from homeopathic manufacturers
• Heather honey: Monofloral honey produced by bees foraging on C. vulgaris flowers, studied separately for its own bioactive properties

2. Traditional and Historical Use

Calluna vulgaris L. (heather) is a traditional medicinal plant with anti-inflammatory and calming activities that are determined by the notable amounts of phytochemicals. Its medicinal use across Europe spans centuries.

2.1 European Folk and Ethnobotanical Traditions

Heather (Calluna vulgaris) has a long history of traditional use in supporting the urinary system, particularly in European herbal medicine. Traditionally, heather flowers and sometimes aerial parts have been used as a diuretic and to help with urinary tract discomfort, cystitis, and mild kidney problems. Scientific studies validating these effects are sparse; most evidence comes from historical herbal texts and anecdotal reports rather than controlled clinical trials.

The plant is traditionally used to treat urinary tract infection and inflammatory disorders. C. vulgaris has been used in ethnopharmacology as an antiseptic, antibacterial, cholagogue, diuretic, expectorant, antirheumatic, and anti-inflammatory agent.

Heather flowers were used in Swedish herbal medicine to treat inflammatory diseases and wounds. According to European folk medicine, heather herb and flowers were traditionally used as a tea for purifying the blood, stimulating metabolism, treating gastrointestinal disorders, and reducing inflammation and gravel of the urinary system.

A large number of plant species are used in Danish folk medicine for treatment of depression and anxiety. One of the three most active extracts was the aqueous extract of aerial parts of C. vulgaris for antidepressive treatment. Anecdotal evidence from Danish folk medicine suggests that the tea of Calluna vulgaris Hull has a nerve calming effect.

2.2 Preparations and Specific Traditional Uses

• Infusion of flowering shoots: An infusion of the flowering shoots is used in the treatment of coughs, colds, bladder and kidney disorders, cystitis, etc.
• Liniment and poultice: The plant is often macerated and made into a liniment for treating rheumatism and arthritis, whilst a hot poultice is a traditional remedy for chilblains.
• Rheumatism and gout: A cleansing and detoxifying plant, it has been used in the treatment of rheumatism, arthritis and gout.
• Sedative and sleep aid: Traditionally used as a mild sedative, usually in the form of tea.
• Bach Flower Remedies: The plant is used in Bach flower remedies — the keywords for prescribing it are "self-centredness" and "self-concern."

3. Key Constituents and Active Compounds

The phytochemical composition of C. vulgaris has indicated the presence of bioactive compounds such as flavonoids, phenols, tannins, proanthocyanidins, caffeic acid derivatives, steroids, triterpenes, and hydroquinones. A body of phytochemical compounds, including phenolic and triterpenic compounds, saponins, hydroquinone glycosides, fatty acids, organic acids, amino acids, polysaccharides, sugars, and vitamins have been detected in plant raw materials of C. vulgaris.

3.1 Phenolic Compounds and Flavonoids

Nineteen phenolic substances have been identified and quantified in extracts by HPLC. The quantitative content of the basic groups of biologically active compounds was determined by spectrophotometry. Arbutin was dominant among the hydroquinone derivatives; chlorogenic acid among the hydroxycinnamic acids; rutin, hyperoside and quercetin-3-D-glucoside among the flavonoids; and (+)-gallocatechin and (-)-epigallocatechin among the tannin metabolites.

A 2018 study published in Food Research International analysing wild-flower nutritional and phytochemical profiles found the following: A high content of fiber and carbohydrates (75%) and the prevalence of α-tocopherol as vitamer deserves attention. Linolenic (35%), linoleic (27%) and palmitic (21%) acids were the most abundant fatty acids. Qualitative and quantitative analysis by LC-MS and 1NMR indicated high levels of quercetin, kaempferol and myricetin derivatives as well as procyanidins. A 2019 study by Mandim et al. published in Food & Function found that it was possible to identify the sugars fructose and glucose, five organic acids, 26 individual fatty acids and the four tocopherol isoforms, and 12 phenolic compounds were identified in the extract composition, with myricetin-3-O-glucoside and myricetin-O-rhamnoside predominating.

3.2 Hydroquinone Derivatives: Arbutin

Arbutin (a hydroquinone glycoside) is a key compound. Arbutin is hydrolysed by intestinal bacteria with release of hydroquinone. This rather reactive molecule is known for its capacity to limit recurrent urinary infections (cystitis) and for its depigmenting power, as it blocks the synthesis of melanin. Arbutin is well documented in the related Ericaceae genus Arctostaphylos uva-ursi (bearberry) as the primary antiseptic principle, and is present in C. vulgaris in measurable quantities.

3.3 Triterpenic Acids

The predominant compounds in the plant raw material of heather were chlorogenic acid, hyperoside, ursolic acid, oleanolic acids, and uvaol. Heather leaves represent a very promising source of triterpenoids. Numerous triterpenoids, including ursolic and oleanolic acid, possess antitumor and anti-inflammatory properties. Triterpenoid substances correspond to 20 to 60% of the weight of the flowers or waxes which cover the leaves; in particular ursolic acid is regarded as protective of tissues, immunomodulatory (antiviral, antibacterial, anti-cancer protection), and anti-inflammatory.

3.4 Tannins and Proanthocyanidins

Heather (Calluna vulgaris), a common dietary component of many mammalian herbivores, contains a broad range of tannin phenolics, flavonoids, and simple phenolic compounds. The tannin fraction includes gallocatechins and epigallocatechins. High concentrations of total phenols in extracts ranged from 67.55 to 142.46 mg GAE/g as examined using the Folin-Ciocalteu reagent. The concentrations of flavonoids in extracts determined by spectrophotometric method ranged from 42.11 to 63.68 mg RUE/g.

3.5 Other Notable Phytochemicals

C. vulgaris compounds including hyperoside, quercitrin, quercetin and kaempferol have been suggested to contribute to photoprotective effects by acting as suppressors of reactive oxygen species production. The plant also contains the alkaloid ericodin, saponins, simple phenolics (including orcinol and quinol), and essential oil minor components.

4. Established Mechanisms of Action

4.1 Antioxidant Mechanisms

Among the most important bioactive compounds identified in C. vulgaris, the phenolic components found in different parts of this herbaceous plant are the main source of its diverse pro-health properties (antioxidant, anti-inflammatory, antimicrobial, chemoprotective, etc.). The hydro-alcoholic extract displayed the highest antioxidant activity and total phenolics (TPC) and flavonoid contents (TFC) in wild-flower studies. Antioxidant activity has been quantified by both ABTS and FRAP assays. A significant diversification of phenolic and triterpenic compounds and antioxidant activity was determined in heather samples collected in distinct habitats.

4.2 Anti-Inflammatory Mechanisms

A new property of ursolic acid has been described in an acetone extract of heather which could help explain the anti-inflammatory characteristics of this plant. Research conducted on SKH-1 hairless mice demonstrated that Calluna vulgaris extract modulates NF-κB/ERK signaling pathway and matrix metalloproteinase expression in mice skin exposed to ultraviolet B irradiation (Filip et al., J Physiol Pharmacol, 2012). Both in vitro and in vivo studies revealed antioxidant and anti-inflammatory effects of C. vulgaris extract. Pretreatment with C. vulgaris extract reduced lipid peroxides and nitric oxide generation and inhibited the UVB-induced apoptosis and inflammation in mice, as well as the formation of DNA photolesions in HaCaT keratinocytes. These effects were assigned to the high content of polyphenols identified in the extract composition.

4.3 Monoamine Oxidase A (MAO-A) Inhibition

A key pharmacological study investigated MAO-A inhibitory activity of a methanol extract of Calluna vulgaris, which traditionally has been used as a nerve calming remedy. A methanolic extract was partitioned against heptane, ethyl acetate and water, and the three fractions were tested in a photometric peroxidase-linked MAO-A bioassay. The ethyl acetate phase showed the highest MAO-A inhibitory activity. Quercetin was isolated through bioassay-guided fractionation. The IC₅₀ value for MAO-A inhibition by quercetin was 18 ± 0.2 μM in an assay where the IC₅₀ value for MAO-A inhibition by clorgyline was 0.2 ± 0.02 μM. The content of quercetin in Calluna vulgaris might explain the reported nerve calming effect of the plant.

The depression-associated disorders were studied by Saaby et al. (2009), who found that the main biologically active compound responsible for the nerve-calming effects of the heather plant was quercetin, which was able to inhibit monoamine oxidase A (MAO-A). It is worth noting that MAO-A is the main compound responsible for the alteration of important neurotransmitters, such as serotonin, dopamine and norepinephrine, which are vital for nerve cells and normal brain functioning, thus the inhibition of MAO-A may have crucial effects in preventing depression.

4.4 Antibacterial Mechanisms

The antibacterial effects of various C. vulgaris extracts revealed that phenolic compounds and flavonoids were responsible for bacterial strain growth inhibition. This includes the action of arbutin hydrolysis products in the urinary tract. Antibacterial effects of different extracts of C. vulgaris showed that phenolic compounds and flavonoids were responsible for the growth inhibition of bacterial strains.

4.5 Antiviral Mechanisms

In work studying supercritical fluid extraction of heather, the aim was to assess potential anti-HCV activity of the extracts owing to their triterpenic acid content. Supercritical extraction assays were carried out exploring the pressure range of 20–50 MPa, temperatures of 40–70°C and 0–15% of ethanol cosolvent. The content of oleanolic and ursolic acid in the extracts were determined, and different samples were screened for cellular cytotoxicity and virus inhibition using a HCV cell culture infection system. Antiviral activity was observed in most extracts, and in general, superior anti-HCV activity was observed for higher contents of oleanolic and ursolic acids.

5. Scientific Evidence by Area of Use

5.1 Urinary Tract Health

Type of evidence: In vitro (cell/bacterial studies), no published controlled human clinical trials specifically for C. vulgaris as a standalone urinary treatment.

Calluna vulgaris L. Hull (Ericaceae) has been used for treatment of urinary tract infections in traditional medicine. A study analysed in vitro antibacterial activity of plant extracts on different strains of Escherichia coli, Enterococcus faecalis and Proteus vulgaris, as well as the concentrations of total phenols and flavonoids in the extracts. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined. The aqueous extract of C. vulgaris showed significant antibacterial activity against different strains of E. coli, E. faecalis, and P. vulgaris in an in vitro test. The MIC values for this extract ranged from 2.5 mg/mL to 20 mg/mL.

The results of this research suggest that aqueous, ethanol and ethyl acetate extracts from C. vulgaris, tested in vitro, show great potential as natural antibacterial agents, and may be useful in the treatment of infectious diseases caused by urinary tract pathogens. Aqueous extract may have a significant effect on the prevention of infections of the urinary tract.

A study of Ericaceae-family plants for antimicrobial activity noted that the most prominent antibacterial effect was achieved on Staphylococcus aureus with extracts of Calluna vulgaris and Erica carnea. However, the antimicrobial activity of the ethanolic extracts against 10 tested strains was generally weak, even for samples where HPLC confirmed the presence of arbutin.

Evidence strength: Preliminary, in vitro only. No randomized controlled trials (RCTs) in humans have been published specifically for C. vulgaris as a treatment for urinary tract infections as of the available literature.

5.2 Anti-Inflammatory Activity

Type of evidence: In vitro and animal (rodent) studies.

The water and hydroethanolic extract were compared; the extract of C. vulgaris herb obtained with 70% hydroethanolic had the most pronounced anti-inflammatory, antimicrobial, anxiolytic, stress-protective, anti-anxiety and anti-depressant effects, and is a promising substance for the development of new drugs or food supplements.

Compared to a control, an anti-exudative effect of the C. vulgaris dry extract (DECV) was observed within the first hour after the start of treatment and reached its maximum values at the third and fifth hour, depending on the solvent of the extract. The hydroethanolic DECV showed the highest anti-inflammatory activity among all tested extracts. During the first hour of the experiment, the most pronounced anti-inflammatory activity was shown by the reference drug (Hypericum tincture), which reduced oedema by 37.30% compared to the control. However, at the third and fifth hour of the experiment, the anti-exudative activity of the reference drug decreased slightly compared to the hydroethanolic DECV.

The more polar extracts showed not only the highest amount in phenolic compounds, but also the strongest antioxidant and antibacterial activities. In contrast, for the anti-inflammatory and cytotoxic potential, the most effective extracts were the n-hexane and the ethyl acetate extracts, respectively.

Evidence strength: Preclinical (in vitro and rodent models). Anti-inflammatory activity is a consistently replicated finding across multiple extract types, but human clinical evidence is absent.

5.3 Neurotropic / Anxiolytic / Antidepressant Activity

Type of evidence: In vitro enzyme assay and animal (rodent) behavioural studies.

Similar antidepressant, anti-anxiety, neurotropic and anxiolytic effects were observed by Starchenko et al. (2020) using an in vivo study model on rats and mice. The mechanistic basis for the nerve-calming effect in Danish folk medicine was formally investigated by Saaby et al. (2009) in Journal of Ethnopharmacology, using bioassay-guided fractionation of C. vulgaris methanol extract; quercetin was identified as the active MAO-A inhibitory compound. Quercetin was isolated from the methanolic extract of heather (Calluna vulgaris (L.) Hull–Ericaceae) and was evaluated for MAO inhibition; by exhibiting an IC₅₀ value of 18 μM, quercetin was distinguished as a selective MAO-A inhibitor. However, clorgyline, an MAO-A selective inhibitor, showed an IC₅₀ value of 0.2 μM in the same assay, indicating that quercetin from heather is appreciably weaker than a pharmaceutical MAO-A inhibitor.

Evidence strength: In vitro and animal only. The MAO-A inhibitory activity of quercetin isolated from C. vulgaris is well-documented in vitro, but no human clinical trials for mood or anxiety outcomes have been published for the plant extract.

5.4 Photoprotection and Skin Health

Type of evidence: In vitro (keratinocyte cell lines) and animal (hairless mouse) studies.

The chemoprotective effect of C. vulgaris extract was evidenced in different studies that emphasised that the extract can be used for skin burns and skin cancer prevention, as part of a hydrogel before UVB exposure, or as an inhibitor agent of UVB-induced cell death. Virag et al. (2015) underlined the photoprotective effects of heather by suggesting that it acts as a suppressant to the production of reactive oxygen species because of its compounds, namely hyperoside, quercitrin, quercetin and kaempferol.

The study by Filip et al. (2012), published in Journal of Physiology and Pharmacology, showed that C. vulgaris extract modulates the NF-κB/ERK signaling pathway and matrix metalloproteinase expression in SKH-1 hairless mouse skin exposed to UVB irradiation. Pretreatment with C. vulgaris and reference extracts resulted in significantly reduced levels of IL-6 and TNF-α compared with UVB alone (p<0.0001).

The hydro-alcoholic extract displayed the highest antioxidant activity and total phenolics and flavonoid contents. No adverse effects on cells were observed until a concentration of 100 μg/mL.

Evidence strength: Preclinical. In vitro and animal data consistently support photoprotective/chemopreventive activity, but human clinical trials are lacking.

5.5 Antiviral Activity (Hepatitis C Virus)

Type of evidence: In vitro (cell culture) study.

Other pharmacological effects of C. vulgaris include antiviral properties indicated by the presence of oleanolic and ursolic acid, which showed a high Hepatitis C virus inhibition in the ethyl acetate fractions. García-Risco et al. (2015) published in Virus Research that supercritical fluid extraction of heather yielded triterpenic-acid-rich extracts; the content of oleanolic and ursolic acid in the extracts was determined, and different samples were screened for cellular cytotoxicity and virus inhibition using a HCV cell culture infection system. Antiviral activity was observed in most extracts, and in general, superior anti-HCV activity was observed for higher contents of oleanolic and ursolic acids.

Evidence strength: Very preliminary, in vitro only. No human or animal efficacy studies on C. vulgaris for hepatitis C have been published.

5.6 Antiproliferative and Chemopreventive Activity

Type of evidence: In vitro.

Ursolic acid isolated from heather flowers showed antiproliferative activity. The authors (Simon et al., 1992) revealed that this compound has an increased role in inhibiting lipoxygenase activity and thus the proliferation of HL60 leukemic cells in a dose-dependent manner. This finding is specific to isolated ursolic acid tested against a leukemic cell line and has not been replicated in humans or whole animals using heather preparations.

Evidence strength: In vitro only, with isolated compound. No clinical evidence.

5.7 Vaginal Microbiota and Antibacterial Selectivity

Type of evidence: In vitro.

The 2019 Mandim et al. studies published in Food & Function specifically investigated the effect of C. vulgaris inflorescence extracts on vaginal microbiota. C. vulgaris presented a wide range of biological effects, highlighting their capacity to inhibit pathogenic bacteria without affecting beneficial microflora, corroborating their use in traditional medicine.

Evidence strength: In vitro only; no clinical evidence on vaginal health outcomes.

6. Body Systems and Health Areas Associated with C. vulgaris

Based on the available preclinical literature, C. vulgaris is associated with the following body systems and health areas:

• Urinary system: Various pharmacological effects have been reported such as anti-inflammatory, antiseptic, sedative, diuretic, antiviral, cytotoxic, antiproliferative, antibacterial, cardioprotective, hepatoprotective, and antioxidant effects. Its traditional urinary tract applications are supported by in vitro antibacterial evidence.
• Central nervous system (mood, anxiety, sleep): Quercetin-mediated MAO-A inhibition and rodent behavioural studies suggest neurotropic potential.
• Musculoskeletal system: Traditional use for rheumatism, arthritis, gout, and chilblains, supported by some in vitro and animal anti-inflammatory data.
• Skin and integument: Photoprotective and anti-inflammatory preclinical evidence; arbutin has a documented skin-depigmenting (skin-lightening) mechanism.
• Respiratory system: Traditional use as an expectorant and treatment for coughs and colds.
• Gastrointestinal system: Traditional use for diarrhoea, stomach pain, and colic; cholagogue (bile-promoting) activity is recorded in ethnopharmacology.
• Cardiovascular system: Some cardioprotective and antihypertensive effects have been reported in the pharmacological literature but remain at the preclinical level.

7. Dosage Forms and Dosages Reported in Studies

There are no established, regulatory-approved human clinical dosage guidelines for Calluna vulgaris as a medicinal preparation. The following are dosages and preparations specifically reported in or cited by research sources:

• In vitro antibacterial studies (MIC range): The aqueous extract showed significant antibacterial activity against different strains of E. coli, E. faecalis, and P. vulgaris in an in vitro test. The MIC values for this extract ranged from 2.5 mg/mL to 20 mg/mL.
• MAO-A inhibition (in vitro): The IC₅₀ value for MAO-A inhibition by quercetin isolated from C. vulgaris was 18 ± 0.2 μM in an assay where the IC₅₀ value for MAO-A inhibition by clorgyline was 0.2 ± 0.02 μM.
• In vitro cytotoxicity (safe concentration): No adverse effects on cells were observed until a concentration of 100 μg/mL and a good antimicrobial activity was reported against S. epidermidis and S. aureus with the hydro-alcoholic extract.
• Dry extract preparation (pharmacological animal studies): The Starchenko et al. (2020) study used hydroethanolic dry extracts (DECV) prepared with 70% ethanol; the extract of C. vulgaris herb obtained with 70% hydroethanolic had the most pronounced anti-inflammatory, antimicrobial, anxiolytic, stress-protective, anti-anxiety and anti-depressant effects.
• Supercritical CO₂ extraction conditions (laboratory research): Supercritical extraction assays were carried out exploring the pressure range of 20–50 MPa, temperatures of 40–70°C and 0–15% of ethanol cosolvent.

No large-scale human dose-finding or pharmacokinetic studies have been published that establish an evidence-based oral dose for any health indication.

8. Safety Considerations and Interactions

8.1 General Tolerability

Heather (Calluna vulgaris), a common dietary component of many mammalian herbivores, contains a broad range of tannin phenolics, flavonoids, and simple phenolic compounds. These may lead to a number of negative effects on herbivores as a result of toxicity or digestive inhibition. This observation is specific to ruminants that consume heather as a large proportion of their diet; relevance to human supplemental use is uncertain. Specifically, the compounds tested — orcinol, quinol, and arbutin (a glucoside of quinol) — showed that at a concentration of 10 mM, both orcinol and quinol depressed production of gas and volatile fatty acids (VFAs), and orcinol, and to a lesser extent quinol, also reduced digestion of the substrate. These effects are relevant to ruminant biology, not directly to human health at supplemental doses.

8.2 In Vitro Cytotoxicity Threshold

The hydro-alcoholic extract displayed the highest antioxidant activity and total phenolics and flavonoid contents. No adverse effects on cells were observed until a concentration of 100 μg/mL. This is an in vitro finding, and the relationship to human in vivo safety cannot be directly extrapolated.

8.3 Arbutin and Hydroquinone Concerns

The presence of arbutin raises safety considerations relevant to high-dose or long-term use. Arbutin is hydrolysed to hydroquinone. Arbutin is hydrolysed by intestinal bacteria with release of hydroquinone. This rather reactive molecule is known for its capacity to limit recurrent urinary infections (cystitis) and for its depigmenting power, it blocks the synthesis of melanin. Hydroquinone at high doses has known cytotoxic and potentially nephrotoxic properties; this concern has been documented for the related arbutin-bearing plant Arctostaphylos uva-ursi (bearberry) in European regulatory assessments, though the arbutin content in C. vulgaris is generally lower than in bearberry.

8.4 Absence of Clinical Safety Data

No systematic clinical safety studies, randomized controlled trials with safety endpoints, or published human adverse event reports specific to C. vulgaris supplementation were located in the peer-reviewed literature. Scientific studies validating the effects of C. vulgaris are sparse, and most evidence comes from historical herbal texts and anecdotal reports rather than controlled clinical trials.

8.5 MAO-A Inhibition and Drug Interaction Potential

The in vitro identification of MAO-A inhibitory activity from quercetin in C. vulgaris is pharmacologically relevant. MAO-A inhibitors as a drug class are known to interact with serotonergic agents, tyramine-rich foods, and certain sympathomimetics. MAO-A is the main compound responsible for the alteration of important neurotransmitters, such as serotonin, dopamine and norepinephrine, which are vital for nerve cells and normal brain functioning. However, the inhibitory potency of quercetin from heather at achievable dietary concentrations is substantially lower than pharmaceutical MAO inhibitors (IC₅₀ 18 μM for quercetin vs. 0.2 μM for clorgyline). The clinical significance of this interaction in humans consuming heather preparations has not been studied.

8.6 Diuretic Effects

The traditional use of C. vulgaris as a diuretic means that co-administration with pharmaceutical diuretics or lithium (a drug with a narrow therapeutic index affected by hydration status) warrants attention, though this has not been formally studied in clinical settings.

8.7 Pregnancy and Lactation

No published clinical safety data exist for C. vulgaris supplementation during pregnancy or lactation. In the absence of such data, safety during these periods cannot be established from the scientific literature.

8.8 Heather Honey: Distinct Safety Considerations

Heather honey, a product of bees foraging on C. vulgaris, has been studied separately for antimicrobial and antioxidant properties. It has been suggested that heather honey could be employed as an antifungal agent, especially in skin disorders, keeping in mind that in order to assess its contribution to the medical field, future clinical studies on the impact that heather honey has on treating different disorders are needed. Standard honey safety considerations apply, including the contraindication for infants under 12 months due to the risk of botulism.

9. Evidence Summary and Research Gaps

The C. vulgaris plant has manifested important pharmacological activities such as: antibacterial, anti-anxiety/antidepressant/neurotropic, antiviral, antiproliferative, antinociceptive, antioxidant, antihypertensive and analgesic, anti-inflammatory, hypouricemic, and chemopreventive and photoprotective activities. However, the large majority of this evidence remains at the level of in vitro or animal studies.

The rich phytochemical composition suggests Calluna vulgaris aboveground parts as a source of antioxidant active added-value ingredients. The data obtained demonstrated that wild plants like heather, although not being a common nutritional reference, can be used in an alimentary base as a source of bioactive compounds, namely antioxidants.

Critical gaps in the existing evidence base include: (1) the complete absence of published randomized controlled human clinical trials for any health indication; (2) the absence of human pharmacokinetic data; (3) the lack of systematic dose-ranging or dose-response data in humans; (4) the absence of formal clinical drug interaction studies; and (5) the absence of long-term safety studies in any species using standard oral dosage forms. These gaps mean that all purported therapeutic benefits of C. vulgaris preparations should be considered preliminary and hypothesis-generating rather than established.

References

• Cucu AA, Baci GM, Cucu AB, et al. "Calluna vulgaris as a Valuable Source of Bioactive Compounds: Exploring Its Phytochemical Profile, Biological Activities and Apitherapeutic Potential." Plants (Basel). 2022;11(15):1993. PMC
• Starchenko G, Hrytsyk A, Raal A, Koshovyi O. "Phytochemical Profile and Pharmacological Activities of Water and Hydroethanolic Dry Extracts of Calluna vulgaris (L.) Hull. Herb." Plants (Basel). 2020;9(6):751. PMC
• Vučić DM, Petković MR, Rodić-Grabovac BB, et al. "In vitro activity of heather [Calluna vulgaris (L.) Hull] extracts on selected urinary tract pathogens." Bosn J Basic Med Sci. 2014;14(4):234–238. PMC
• Chepel V, Skrypnik L. "Phytochemical Diversity and Antioxidant Potential of Wild Heather (Calluna vulgaris L.) Aboveground Parts." PMC. 2022.
• Rodrigues F, Moreira T, Pinto D, et al. "The phytochemical and bioactivity profiles of wild Calluna vulgaris L. flowers." Food Res Int. 2018;111:724–731. PubMed
• Mandim F, Barros L, Calhelha RC, et al. "Calluna vulgaris (L.) Hull: chemical characterization, evaluation of its bioactive properties and effect on the vaginal microbiota." Food Funct. 2019;10(1):78–89. RSC Publishing
• Saaby L, Rasmussen HB, Jäger AK. "MAO-A inhibitory activity of quercetin from Calluna vulgaris (L.) Hull." J Ethnopharmacol. 2009;121(1):178–181. ScienceDirect
• García-Risco MR, Vázquez E, Sheldon J, et al. "Supercritical fluid extraction of heather (Calluna vulgaris) and evaluation of anti-hepatitis C virus activity of the extracts." Virus Res. 2015;198:9–14. ResearchGate
• Simultaneous Supercritical Fluid Extraction of Heather (Calluna vulgaris L.) and Marigold (Calendula officinalis L.) and Anti-Inflammatory Activity of the Extracts. Appl. Sci. 2019;9(11):2245. MDPI
• Effect of simple phenolic compounds of heather (Calluna vulgaris) on rumen microbial activity in vitro. PubMed. 2014.
• Antimicrobial activity of selected plant species of Genera Arbutus L., Bruckenthalia Rchb., Calluna Salisb. and Erica L. (Ericaceae). AFMN Biomedicine. 2013.
• Filip GA, Postescu D, Tatomir C, Muresan A, Clichici S. "Calluna vulgaris extract modulates NF-κB/ERK signaling pathway and matrix metalloproteinase expression in SKH-1 hairless mice skin exposed to ultraviolet B irradiation." J Physiol Pharmacol. 2012;63(4):423–432.
• Quercetin and Related Chromenone Derivatives as Monoamine Oxidase Inhibitors: Targeting Neurological and Mental Disorders. Molecules. 2019;24(3):418. MDPI
• Multifunctional Therapeutic Potential of Phytocomplexes and Natural Extracts for Antimicrobial Properties. PMC. 2021.
• Phytochemical Diversity and Antioxidant Potential of Wild Heather (Calluna vulgaris L.) Aboveground Parts. PubMed. 2022.